3
Announcements
Trials
Browse
Landscape
Status
Withdrawn
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
3
Study Type
Interventional
63
Observational
3
Sponsor
Cancer Type
Tumor-Agnostic
1
Sarcoma
1
Breast
1
Conditions
Neoplasms, Second Primary
1
Desmoid Tumors
1
Breast Neoplasms
1
Interventions
Surveys and Questionnaires
529
Blood Specimen Collection
406
Surgical Procedures, Operative
152
Radiotherapy
131
Interviews as Topic
131
Drug Therapy
123
Observation
122
Magnetic Resonance Spectroscopy
104
Biopsy
103
Specimen Handling
70
Data Collection
70
Neoadjuvant Therapy
65
Immunohistochemistry
64
Magnetic Resonance Imaging
61
Immune Checkpoint Inhibitors
59
Watchful Waiting
52
Immunotherapy
51
Bevacizumab
50
Positron Emission Tomography Computed Tomography
46
Ultrasonography
44
Hematologic Tests
42
Liquid Biopsy
41
Tomography, X-Ray Computed
40
Therapeutics
40
Radiosurgery
40
Colonoscopy
40
pembrolizumab
37
Hepatectomy
37
Gene Expression Profiling
36
High-Energy Shock Waves
35
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
OTHER
×
Observational
×
Bleomycin
×
Clear all
NCT06660121
2026-05-14
ECT-DESMO
Istituto Ortopedico Rizzoli
Withdrawn
NCT03199300
2025-12-11
InvestiCAT
University Medical Center Groningen
Active not recruiting
20 enrolled
NCT06683404
2024-11-12
GISEL
Istituto Oncologico Veneto IRCCS
Completed
205 enrolled